New Test Helps Evaluate Cancer Drug's Merit
Teach Prescribers About Dangers of Long-Acting Pain Meds: FDA
MONDAY, July 9 (Healthday News) -- A new genetic test to help doctors determine if the drug Erbitux would be an effective treatment for certain colorectal cancer patients has been approved by the U.S. Food and Drug Administration. read more..
source:http://yhoo.it/MXsSEz
Teach Prescribers About Dangers of Long-Acting Pain Meds: FDA
MONDAY, July 9 (Healthday News) -- As part of its efforts to curb the abuse of narcotic painkillers, the U.S. Food and Drug Administration is requiring drug makers to educate doctors about the risks of long-acting and extended-release forms of the drugs. read more..
source:http://yhoo.it/MXsWnD
No comments:
Post a Comment